Results 151 to 160 of about 1,109,482 (395)
Optimizing Interferon Alfa Based Therapy for Chronic Hepatitis C [PDF]
, 2011 The hepatitis C virus was first discovered in 1989 as the major cause of chronic non-A non-B hepatitis. The hepatitis C virus is a single stranded RNA virus that belongs to the family of flaviviruses.
Roomer, R. (Robert)
core
An algorithm for the grading of activity in chronic hepatitis C
Hepatology, 1996 P. Bedossa, T. Poynard
semanticscholar +1 more source
Annals of Gastroenterological Surgery, EarlyView.ROC analyses of APRI score, EOB‐MRI, and a combination of EOB‐MRI and APRI score for blue liver. ABSTRACT Aim Sinusoidal obstruction syndrome (SOS), also known as “blue liver (BL),” is a common hepatic injury following oxaliplatin‐based chemotherapy in patients with colorectal liver metastases (CRLM).
Tomonari Shimagaki +7 more
wiley +1 more source
Hepatology, EarlyView., 2022 Abstract Background and Aims Reliable noninvasive biomarkers are an unmet clinical need for the diagnosis of NASH. This study investigates the diagnostic accuracy of the circulating triggering receptor expressed on myeloid cells 2 (plasma TREM2) as a biomarker for NASH in patients with NAFLD and elevated liver stiffness.
Vineesh Indira Chandran +17 more
wiley +1 more source
Pengaruh Penerapan Universal Precaution (Hand Higiene dan APD) dalam Mencegah Insiden Hepatitis C pada Pasien Hemodialisa di RSU PKU Muhammadiyah YOGYAKARTA [PDF]
, 2015 Background: Hepatitis C is caused by hepatitis C virus (HCV); a small RNA virus which is wrapped by fat, its diameter is around 30 to 60 nm. An acute HCV infection is generally asymptomatic or minimally symptomatic.
Mashuri, M. (Mashuri)
core
Annals of Gastroenterological Surgery, EarlyView.We retrospectively analyzed clinical data from patients who underwent hepatectomy for hepatocellular carcinoma (HCC) using LCA‐based grading system. These findings provide a new risk stratification framework for the design of precision surgery to treat patients with HCC.
Ling Liu +5 more
wiley +1 more source
Hepatology, EarlyView., 2022 Graphical abstract summarizing the study design, main results and key findings Abstract Background and Aims Fatty liver disease (FLD) has been associated with excess mortality. Screening for hepatic steatosis (HS) in patients with metabolic dysfunction is therefore recommended by several guidelines, despite a paucity of evidence on the clinical ...
Laurens A. van Kleef +5 more
wiley +1 more source
Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon [PDF]
, 1993 For the 30-50% of patients with chronic hepatitis C who do not respond to alpha-interferon therapy there is no alternative treatment. Some previously untreated patients have shown a biochemical response to ribavirin, but the antiviral effects of this ...
Camps, J. (J.) +4 more
core